$AKBA stock has now fallen 21% today, according to our price data from Polygon. There has been approximately $6,766,245 of trading volume.
Here is what we see in our data on $AKBA (you can track the company live on Quiver's $AKBA stock page):
$AKBA Insider Trading Activity
$AKBA insiders have traded $AKBA stock on the open market 16 times in the past 6 months. Of those trades, 1 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $AKBA stock by insiders over the last 6 months:
- JOHN P. BUTLER (CEO and President) has made 1 purchase buying 69,270 shares for an estimated $86,587 and 4 sales selling 341,305 shares for an estimated $474,413.
- NICHOLAS GRUND (Chief Commercial Officer) has made 0 purchases and 2 sales selling 84,829 shares for an estimated $117,912.
- CAROLYN M. RUCCI (SVP, Chief Legal Officer) has made 0 purchases and 3 sales selling 69,772 shares for an estimated $96,983.
- STEVEN KEITH BURKE (SVP, Chief Medical Officer) has made 0 purchases and 3 sales selling 67,658 shares for an estimated $94,044.
- RICHARD C MALABRE (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 49,524 shares for an estimated $68,838.
- ERIK OSTROWSKI (SVP, CFO, CBO & Treasurer) sold 34,951 shares for an estimated $48,581
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$AKBA Hedge Fund Activity
We have seen 89 institutional investors add shares of $AKBA stock to their portfolio, and 80 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 3,086,385 shares (-71.5%) from their portfolio in Q4 2025, for an estimated $4,969,079
- MPM BIOIMPACT LLC removed 2,889,125 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,651,491
- FRANKLIN RESOURCES INC removed 2,498,569 shares (-93.2%) from their portfolio in Q4 2025, for an estimated $4,022,696
- AFFINITY ASSET ADVISORS, LLC removed 2,450,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,944,500
- STATE STREET CORP added 1,842,792 shares (+15.6%) to their portfolio in Q4 2025, for an estimated $2,966,895
- INVESCO LTD. removed 1,731,567 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $2,787,822
- HRT FINANCIAL LP added 1,594,539 shares (+6430.4%) to their portfolio in Q4 2025, for an estimated $2,567,207
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$AKBA Analyst Ratings
Wall Street analysts have issued reports on $AKBA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/25/2026
To track analyst ratings and price targets for $AKBA, check out Quiver Quantitative's $AKBA forecast page.
$AKBA Price Targets
Multiple analysts have issued price targets for $AKBA recently. We have seen 3 analysts offer price targets for $AKBA in the last 6 months, with a median target of $4.0.
Here are some recent targets:
- Julian Harrison from BTIG set a target price of $4.0 on 04/07/2026
- Matthew Caufield from HC Wainwright & Co. set a target price of $6.0 on 02/06/2026
- Allison Bratzel from Piper Sandler set a target price of $4.0 on 02/06/2026
You can track data on $AKBA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
